rs35154632
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001042413.2(GLIS3):āc.938G>Cā(p.Gly313Ala) variant causes a missense change. The variant allele was found at a frequency of 0.00913 in 1,614,206 control chromosomes in the GnomAD database, including 74 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.011 ( 8 hom., cov: 32)
Exomes š: 0.0090 ( 66 hom. )
Consequence
GLIS3
NM_001042413.2 missense
NM_001042413.2 missense
Scores
4
7
7
Clinical Significance
Conservation
PhyloP100: 5.02
Genes affected
GLIS3 (HGNC:28510): (GLIS family zinc finger 3) This gene is a member of the GLI-similar zinc finger protein family and encodes a nuclear protein with five C2H2-type zinc finger domains. This protein functions as both a repressor and activator of transcription and is specifically involved in the development of pancreatic beta cells, the thyroid, eye, liver and kidney. Mutations in this gene have been associated with neonatal diabetes and congenital hypothyroidism (NDH). Alternatively spliced variants that encode different protein isoforms have been described but the full-length nature of only two have been determined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.009075195).
BP6
Variant 9-4118540-C-G is Benign according to our data. Variant chr9-4118540-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 129156.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-4118540-C-G is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.0107 (1628/152320) while in subpopulation AFR AF= 0.0153 (636/41576). AF 95% confidence interval is 0.0143. There are 8 homozygotes in gnomad4. There are 836 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 8 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GLIS3 | NM_001042413.2 | c.938G>C | p.Gly313Ala | missense_variant | 4/11 | ENST00000381971.8 | NP_001035878.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GLIS3 | ENST00000381971.8 | c.938G>C | p.Gly313Ala | missense_variant | 4/11 | 5 | NM_001042413.2 | ENSP00000371398 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0106 AC: 1619AN: 152202Hom.: 8 Cov.: 32
GnomAD3 genomes
AF:
AC:
1619
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00733 AC: 1843AN: 251470Hom.: 14 AF XY: 0.00726 AC XY: 987AN XY: 135910
GnomAD3 exomes
AF:
AC:
1843
AN:
251470
Hom.:
AF XY:
AC XY:
987
AN XY:
135910
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00897 AC: 13116AN: 1461886Hom.: 66 Cov.: 36 AF XY: 0.00880 AC XY: 6399AN XY: 727242
GnomAD4 exome
AF:
AC:
13116
AN:
1461886
Hom.:
Cov.:
36
AF XY:
AC XY:
6399
AN XY:
727242
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0107 AC: 1628AN: 152320Hom.: 8 Cov.: 32 AF XY: 0.0112 AC XY: 836AN XY: 74490
GnomAD4 genome
AF:
AC:
1628
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
836
AN XY:
74490
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
39
ALSPAC
AF:
AC:
27
ESP6500AA
AF:
AC:
88
ESP6500EA
AF:
AC:
79
ExAC
AF:
AC:
941
Asia WGS
AF:
AC:
37
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | GLIS3: BS1, BS2 - |
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Jan 13, 2020 | This variant is associated with the following publications: (PMID: 32425884, 31287502) - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
not specified Benign:2
Likely benign, no assertion criteria provided | clinical testing | Genetic Services Laboratory, University of Chicago | - | Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. - |
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Neonatal diabetes mellitus with congenital hypothyroidism Benign:2
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | May 01, 2017 | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). No publications were found based on this search. Allele frequency data from public databases was too high to be consistent with this variant causing disease. Therefore, this variant is classified as benign. - |
Benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Jul 19, 2021 | - - |
Monogenic diabetes Benign:1
Benign, criteria provided, single submitter | research | Personalized Diabetes Medicine Program, University of Maryland School of Medicine | Feb 01, 2019 | ACMG criteria: BA1 (1.63% in gnomAD African, 0.7% overall), BS2 (17 homozygotes in gnomAD)=benign (REVEL 0.206 +PP3/7 predictors + BP4/3 predictors: conflicting evidence, not using) - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;.
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
MutationTaster
Benign
D;D
PrimateAI
Pathogenic
D
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
D;D
Vest4
MVP
MPC
0.22
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at